AI assistant
Sending…
RESMED INC — Director's Dealing 2019
Nov 20, 2019
30071_dirs_2019-11-20_e27fac81-5143-4ab4-8456-66d87d31660b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-18
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-18 | ResMed Common Stock | S | 1360 | $146.70 | Disposed | 154026 | Indirect |
| 2019-11-18 | ResMed Common Stock | G | 680 | — | Disposed | 153346 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 34609 | Direct |
Footnotes
F1: Gift of shares to The Douglas Family Fund, a donor advised charitable fund. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29